MobileMedMinder: A Networked Aide for Medication Compliance

MobileMedMinder：药物合规性的网络助手

• 批准号: 8332233
• 负责人: HUIPING LI
• 金额: $ 49.98万
• 依托单位: LIMAGING, LLC
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-09-30 至 2012-09-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8332233
• 关键词: Academic Medical Centers; Award; Car Phone; Caregivers; Chronic Disease; Client; Collaborations; Communication; Computer software; Contracts; Development; Devices; Diabetes Mellitus; Disease Management; Electronics; Enrollment; Goals; Hypertension; Intake; Internet; Link; Measures; Mental Depression; Methodology; Methods; Monitor; Ohio; Patients; Pharmaceutical Preparations; Phase; Physicians; Randomized Controlled Trials; Recommendation; Services; Small Business Innovation Research Grant; Social Network; Solutions; Study Subject; System; Testing; Time; Wireless Technology; base; behavior change; compliance behavior; medication compliance; prototype; trial comparing; usability; voice recognition

Under Phase I of the project (SBIR PHS 2008-1, "Development of Methodology for Measuring and Enhancing Compliance for Medications, Topic 33), the MobileMedMinder was successfully demonstrated. Phase II will involve collaboration to develop and commercialize the MobileMedMinder. This product will allow users to enroll and verify medication intake using the existing mobile devices, and link seemlessly to web through wireless. MobileMedMinder will provide the following: 1) automatic or simi-automatic entry of medication information through Medscanning, electronic pick lists, voice recognition. 2) Real-time communication with an on-line server where medication can be monitored and recommendations made from automated systems, caregivers or physicians directly or through social networking solutions. 3) If successful, MobileMedMinder can be extended as a mobile platform for chronic disease management system, such as diabetes, depression, hypertension, etc. A user-centered usability testing and subject study at the Ohio State University Medical Center managed by collaborator, Robert M. Guthrie, M.D., is planned to provide a comprehensive, non-intrusive, portable solution in support of medication compliance. The ultimate goal is to develop a product for use by patients on a mobile/web platform to promote medication compliance and behavior change that can be subsequently commercialized.

在该项目的第一阶段（SBIR PHS 2008-1，“测量和增强药物依从性的方法学开发，主题33），MobileMedMinder得到了成功演示。第二阶段将涉及合作开发和商业化MobileMedMinder。该产品将允许用户使用现有的移动的设备注册和验证药物摄入，并通过无线无障碍地链接到Web。 MobileMedMinder将提供以下功能：1）通过Medscanning、电子选择列表、语音识别自动或半自动输入药物信息。2)与在线服务器进行实时通信，可以监控药物，并直接或通过社交网络解决方案从自动化系统，护理人员或医生那里提出建议。3)如果成功，MobileMedMinder可以扩展为一个移动的平台，用于慢性病管理系统，如糖尿病、抑郁症、高血压等。 在俄亥俄州州立大学医学中心进行的一项以用户为中心的可用性测试和主题研究，由合作者Robert M.医学博士古特里计划提供一个全面的，非侵入性的，便携式的解决方案，以支持药物依从性。最终目标是开发一种产品，供患者在移动的/网络平台上使用，以促进药物依从性和行为改变，随后可以商业化。